Immunogenicity of constitutively active V599EBRaf

Activating BRAF somatic missense mutations within the kinase domain are present in 60-66% of melanomas. The vast majority of these represent a single substitution of glutamate for valine (V599E). Here, we demonstrate spontaneous HLA-B*2705-restricted cytotoxic T-cell responses against an epitope der...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Andersen, Mads Hald (VerfasserIn) , Ugurel, Selma (VerfasserIn) , Schadendorf, Dirk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2, 2004
In: Cancer research
Year: 2004, Jahrgang: 64, Heft: 15, Pages: 5456-5460
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-04-0937
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/0008-5472.CAN-04-0937
Verlag, lizenzpflichtig, Volltext: https://cancerres.aacrjournals.org/content/64/15/5456
Volltext
Verfasserangaben:Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, and Jürgen C. Becker

MARC

LEADER 00000caa a2200000 c 4500
001 1742485235
003 DE-627
005 20220819051357.0
007 cr uuu---uuuuu
008 201210s2004 xx |||||o 00| ||eng c
024 7 |a 10.1158/0008-5472.CAN-04-0937  |2 doi 
035 |a (DE-627)1742485235 
035 |a (DE-599)KXP1742485235 
035 |a (OCoLC)1341383379 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Andersen, Mads Hald  |e VerfasserIn  |0 (DE-588)122312181X  |0 (DE-627)1742485928  |4 aut 
245 1 0 |a Immunogenicity of constitutively active V599EBRaf  |c Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, and Jürgen C. Becker 
246 3 3 |a Immunogenicity of constitutively active V599E BRaf 
264 1 |c August 2, 2004 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.12.2020 
500 |a Im Titel ist der Ausdruck "V599E" hochgestellt 
520 |a Activating BRAF somatic missense mutations within the kinase domain are present in 60-66% of melanomas. The vast majority of these represent a single substitution of glutamate for valine (V599E). Here, we demonstrate spontaneous HLA-B*2705-restricted cytotoxic T-cell responses against an epitope derived from V599EBRaf. These T-cell responses were mutation specific as the corresponding epitope derived from wild-type BRaf was not recognized. The loss of the V599EBRAF genotype during progression from primary to metastatic melanoma in patients with V599EBRaf specific T-cell responses suggests an active immune selection of nonmutated melanoma clones by the tumor-bearing host. 
700 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
773 0 8 |i Enthalten in  |t Cancer research  |d Philadelphia, Pa. : AACR, 1941  |g 64(2004), 15, Seite 5456-5460  |h Online-Ressource  |w (DE-627)325489955  |w (DE-600)2036785-5  |w (DE-576)094502226  |x 1538-7445  |7 nnas  |a Immunogenicity of constitutively active V599EBRaf 
773 1 8 |g volume:64  |g year:2004  |g number:15  |g pages:5456-5460  |g extent:5  |a Immunogenicity of constitutively active V599EBRaf 
856 4 0 |u https://doi.org/10.1158/0008-5472.CAN-04-0937  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://cancerres.aacrjournals.org/content/64/15/5456  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201210 
993 |a Article 
994 |a 2004 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 8 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |d 910000  |d 950000  |d 950950  |e 910000PU122030923  |e 950000PU122030923  |e 950950PU122030923  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950950/  |p 3 
999 |a KXP-PPN1742485235  |e 3822458775 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"5 S."}],"id":{"eki":["1742485235"],"doi":["10.1158/0008-5472.CAN-04-0937"]},"name":{"displayForm":["Mads Hald Andersen, Joachim Fensterle, Selma Ugurel, Sine Reker, Roland Houben, Per Guldberg, Thomas G. Berger, Dirk Schadendorf, Uwe Trefzer, Eva-B. Bröcker, Per thor Straten, Ulf R. Rapp, and Jürgen C. Becker"]},"origin":[{"dateIssuedKey":"2004","dateIssuedDisp":"August 2, 2004"}],"relHost":[{"id":{"zdb":["2036785-5"],"eki":["325489955"],"issn":["1538-7445"]},"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"name":{"displayForm":["American Association for Cancer Research"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Philadelphia, Pa.","dateIssuedKey":"1941","publisher":"AACR","dateIssuedDisp":"1941-"}],"note":["Gesehen am 31.03.25","Fortsetzung der Druck-Ausgabe"],"title":[{"title_sort":"Cancer research","title":"Cancer research"}],"language":["eng"],"pubHistory":["Volume 1, issue 1 (1 January 1941)-"],"recId":"325489955","part":{"extent":"5","year":"2004","pages":"5456-5460","text":"64(2004), 15, Seite 5456-5460","issue":"15","volume":"64"},"disp":"Immunogenicity of constitutively active V599EBRafCancer research"}],"recId":"1742485235","language":["eng"],"title":[{"title":"Immunogenicity of constitutively active V599EBRaf","title_sort":"Immunogenicity of constitutively active V599EBRaf"}],"note":["Gesehen am 10.12.2020","Im Titel ist der Ausdruck \"V599E\" hochgestellt"],"titleAlt":[{"title":"Immunogenicity of constitutively active V599E BRaf"}],"person":[{"role":"aut","given":"Mads Hald","display":"Andersen, Mads Hald","family":"Andersen"},{"role":"aut","given":"Selma","display":"Ugurel, Selma","family":"Ugurel"},{"role":"aut","given":"Dirk","display":"Schadendorf, Dirk","family":"Schadendorf"}]} 
SRT |a ANDERSENMAIMMUNOGENI2200